Meeting
2022 ASCO Quality Care Symposium
Investigating keratinocyte growth factor hair serum for the prevention of chemotherapy-induced alopecia.
Authors
Preethika Potluri
Baylor University, Waco, TX
Preethika Potluri, Emma Elizabeth Paul, Jennifer Margaret Segar, Sima Ehsani, Sao Jiralerspong, Denise Roe, Pavani Chalasani
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Palliative and Supportive Care,Technology and Innovation in Quality of Care,Quality, Safety, and Implementation Science
Sub Track
Toxicity Prevention, Assessment, and Management
Clinical Trial Registration Number
NCT04554732
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 240)
DOI
10.1200/JCO.2022.40.28_suppl.240
Abstract #
240
Poster Bd #
C7
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Hair Safe Study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer therapy—A prospective interventional study.
First Author: Christine Brunner
Poster
2017 ASCO Annual Meeting
Scalp Cooling Alopecia Prevention trial (SCALP) for patients with early stage breast cancer.
First Author: Julie R. Nangia
Poster
2011 ASCO Annual Meeting
Clinical performance, efficacy, and safety of the DigniCap system, a scalp-hypothermia system, in preventing chemotherapy (CTX)-induced alopecia in patients (pts) with early-stage breast cancer (BC).
First Author: A. Glencer
Poster
2016 ASCO Annual Meeting
Scalp cooling alopecia prevention trial (SCALP) for patients with early stage breast cancer.
First Author: Julie R. Nangia